Nasdaq Investment Intelligence Content Hub Thematic Tech ETFs to Access Innovative Growth Ideas By Max ChenJuly 30, 2020
Innovative ETFs Content Hub Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research By Max ChenJuly 7, 2020
Innovative ETFs Content Hub Biotech ETFs Rally After Inovio Locks in DOD Coronavirus Deal By Max ChenJune 23, 2020
Innovative ETFs Content Hub Biotech ETFs Surge After Invitae Acquires ArcherDX By Max ChenJune 22, 2020
ETF Building Blocks Content Hub Biotech ETF Doesn’t Need Coronavirus Vaccines to Soar By Tom LydonJune 2, 2020
Disruptive Technology Content Hub Why ETF Investors Should Consider Allocating to Innovation By Max ChenMay 14, 2020
Disruptive Technology Content Hub Making the Case for Innovation: Rethinking Traditional Asset Allocation By Max ChenMay 13, 2020
Disruptive Technology Content Hub ETFs to Tap into Disruptive Technologies That Can Revolutionize the World By Max ChenMarch 2, 2020
Disruptive Technology Content Hub A Targeted Biotech ETF Is Brushing Off the Selling By Max ChenFebruary 27, 2020
Disruptive Technology Content Hub Biotech ETFs Are Not Riding the Wave from Coronavirus Panic By Max ChenJanuary 24, 2020
Disruptive Technology Content Hub Targeted ETFs to Hone in on Innovative Growth Ideas for 2020 By Max ChenJanuary 23, 2020
Disruptive Technology Content Hub Actively Managed ETFs Provide Forward-Looking Strategies By Max ChenDecember 19, 2019
Investing Biotech ETFs Slip as Trump Administration Pushes for Cheap Drug Imports By Max ChenDecember 18, 2019
